Caribou Biosciences
IPODeveloping Sophisticated Allogeneic Cell Therapies
Public · Berkeley, United States · Founded 2011 · $181.0M raised
- Headquarters
- Berkeley, California
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- cariboubio.com
- Total Funding
- $181.0M
- Last Round
- $25.0M Corporate RoundJul 2023
- Rounds
- 4
- Type
- Public
About
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Its proprietary Cas12a chRDNA (CRISPR hybrid RNA-DNA) genome-editing platform enables superior precision for complex multiplex editing, including gene knockout and insertion. Caribou is advancing CB-010 and CB-011 as off-the-shelf allogeneic CAR-T cell therapies targeting hematologic malignancies.
Summary
Caribou Biosciences is a Biotech company based in Berkeley, United States, founded in 2011. It has raised $181.0M in total across 4 rounds, most recently a $25.0M Corporate Round round in Jul 2023. Investors include Pfizer Ventures, Fidelity Biosciences and AbbVie Ventures.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2023
Sign up to see all 5 rounds
Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/caribou-biosciences"><img src="https://indexed.vc/api/badge/company/caribou-biosciences" alt="Caribou Biosciences on Indexed.vc" width="260" height="76" /></a>